Société de Therapeutique Marocaine S.A. (CBSE:SOT)

CBSE:SOT Cash Flow Statement

Financials in millions MAD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	315.29	262.76	266.62	278.85	230.2
Depreciation & Amortization	63.69	54.64	57.18	54.63	44.62
Other Amortization	1.61	-	-	-	-
Loss (Gain) From Sale of Assets	-16.36	-0.12	5.85	-0.03	-0.15
Loss (Gain) on Equity Investments	0.64	0.33	0.02	0.12	0.13
Other Operating Activities	62.93	-0.79	0.39	24.02	9.01
Change in Other Net Operating Assets	-194.15	-216.86	-173.62	-29.9	-189.95
Operating Cash Flow	233.65	99.95	156.43	327.69	93.85
Operating Cash Flow Growth	133.78%	-36.11%	-52.26%	249.17%	-58.74%
Capital Expenditures	-112.71	-117.67	-70.1	-62.56	-59.17
Sale of Property, Plant & Equipment	0.04	73.31	0	0.03	1.52
Divestitures	23.37	-	-	-	-
Investment in Securities	-	-	-21.6	-	-
Other Investing Activities	0	3.48	9	-	10.18
Investing Cash Flow	-87.45	-42.8	-82.78	-62.55	-47.57
Long-Term Debt Issued	200	154.2	80.21	10.21	65.68
Long-Term Debt Repaid	-174.4	-16.22	-40.19	-40.43	-38.7
Net Debt Issued (Repaid)	25.6	137.98	40.03	-30.22	26.98
Common Dividends Paid	-122.4	-180	-180	-151.2	-120.6
Other Financing Activities	-16.34	-23.93	20.03	-18.83	28.6
Financing Cash Flow	-113.14	-65.95	-119.95	-200.25	-65.02
Foreign Exchange Rate Adjustments	-0.33	-0.06	0.21	-0.21	0.09
Net Cash Flow	32.74	-8.86	-46.09	64.69	-18.65
Free Cash Flow	120.94	-17.72	86.33	265.13	34.68
Free Cash Flow Growth	-	-	-67.44%	664.47%	-77.64%
Free Cash Flow Margin	4.29%	-0.71%	3.75%	12.90%	1.93%
Free Cash Flow Per Share	16.80	-2.46	11.99	36.82	4.82
Cash Interest Paid	-	-	-	-	9.67
Cash Income Tax Paid	153.88	146.34	154.5	112.47	112.88
Levered Free Cash Flow	62.43	-63.76	67.63	338.99	44.86
Unlevered Free Cash Flow	81.93	-51.03	73.9	344.68	51.78

Source: S&P Global Market Intelligence. Standard template. Financial Sources.